TP53 and myelodysplastic syndrome: In MDS with a single TP53mut with VAF < 50%, verification of loss of heterozygosity (LOH) or copy-neutral LOH (cnLOH) of the TP53 locus by CNV analysis is mandatory for defining MDS-biTP53 inactivation.